Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium

NCT00014274 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

238

Enrollment

NETWORK

Sponsor class

Conditions

Bladder Cancer
Transitional Cell Cancer of the Renal Pelvis and Ureter
Urethral Cancer

Interventions

DRUG: carboplatin
DRUG: gemcitabine hydrochloride
DRUG: methotrexate
DRUG: vinblastine sulfate

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC